Analyst Actions -- 11/9/2011

 | Nov 09, 2011 | 9:46 AM EST  | Comments
  • Comment
  • Print Print
  • Print
Stock quotes in this article:

tol

,

wag

,

nvda

,

lly

,

adbe

,

hpq

,

via.b

Activision Blizzard estimates, target increased at BMO

Shares of ATVI now seen reaching $17, according to BMO Capital Markets.  Estimates also increased on strong performances by Call of Duty and World of Warcraft.  Outperform rating. 

-----

Activision Blizzard estimates increased at Citigroup

ATVI estimates raised through 2012, Citigroup said.  Strong beat and raise 3Q.  Maintain $16 price target and Buy rating. 

-----

Adobe Systems estimates, target lowered at Jefferies

Shares of ADBE now seen reaching $35, according to Jefferies. Estimates also lowered as risk of growth reset has diminished. Buy rating.

-----

Amdocs estimates lowered at Citigroup

DOX estimates lowered through 2013, Citigroup said.  Modestly lower near term organic revenue growth.  Maintain $37 price target and Buy rating. 

-----

Amylin Pharmaceuticals upgraded at BMO

AMLN was upgraded from Market Perform to Outperform, BMO Capital Markets said.  $17 price target.  Confidence in BYDUREON approval. 

-----

Ares Capital estimates increased at UBS

ARCC estimates increased through 2012, UBS said.  3Q results show value of platform.  Maintain $19 price target and buy rating.

-----

Autodesk downgraded at BofA/Merrill

ADSK was downgraded from Buy to Neutral, Bank of America/Merrill Lynch said. $38 price target. Recent reseller survey was downbeat. Company is also leveraged to weaker growth in Europe.

-----

Babcock & Wilcox numbers boosted at Credit Suisse

Shares of BWC now seen reaching $25, according to Credit Suisse. Estimates also upped, as the company is seeing higher growth across the board. Neutral rating.

-----

Big Lots rated new Hold at Keybanc

BIG was initiated with a Hold rating, Keybanc said. Company is a market leader, but lacks near-term catalysts.

-----

BJ's Restaurants numbers raised at Oppenheimer

Shares of BJRI now seen $62, according to Oppenheimer. Estimates also boosted, as the company should continue to deliver solid growth. Outperform rating.

-----

Eli Lilly target reduced at Credit Suisse

Shares of LLY now seen reaching $37, according to Credit Suisse. Company ceded control of exenatide to Amylin. Neutral rating.

-----

Franklin Resources numbers increased at Sterne Agee

BEN estimates were raised through 2013, Sterne Agee said. Company is seeing strong asset growth. Buy rating and new $134 price target.

-----

Globe Specialty Metals estimates, target lowered at Jefferies

Shares of GSM now seen reaching $22.50, according to Jefferies. Estimates also lowered on a more conservative outlook for silicon metal contract prices. Buy rating.

-----

GNC estimates, target raised at Morgan Stanley

Shares of GNC now seen reaching $31, according to Morgan Stanley. Estimates also increased, given solid comp sales growth. Overweight rating.

-----

H&R Block upgraded at Oppenheimer

HRB was upgraded from Perform to Outperform, Oppenheimer said. $19 price target. Company has multiple potential catalysts.

-----

Hewlett Packard estimates, target lowered at Jefferies

Shares of HPQ now seen reaching $35, according to Jefferies. Estimates also lowered as Thailand floods create shortfall in April quarter. Buy rating.

-----

Hibbett Sports downgraded at Longbow

HIBB was downgraded from Buy to Neutral, Longbow said. Valuation call, as the stock has gained 21% year-to-date.

-----

HollyFrontier estimates, target cut at Credit Suisse

Shares of HFC now seen reaching $47, according to Credit Suisse. Company will likely invest more toward future growth.

-----

Int'l Flavors & Fragrances numbers lowered at Credit Suisse

IFF estimates were cut through 2012, Credit Suisse said. Company has limited near-term visibility. Outperform rating and new $66 price target.

-----

Medicis target increased at UBS

MRX price target raised to $39, UBS said.  3Q missed consensus, but in guided range.  Neutral rating.

-----

Medicis downgraded at Wells

MRX was downgraded from Outperform to Market Perform, Wells Fargo said. Company faces potential growth headwinds.

-----

Netsuite rated new Outperform at Wells

Coverage of N was started with an Outperform rating, Wells Fargo said. Company is leveraged to secular growth in cloud computing.

-----

Noble Energy target raised at UBS

NBL price target increased to $113, UBS said.  Expect 2012 production guidance and improved long term growth outlook.  Buy rating.

-----

Nvidia downgraded at JMP

NVDA was downgraded to Market Perform, JMP Securities said. Estimates also cut, as the Tegra initiative is facing increased competition. $18 price target.

-----

Quality Systems upgraded at Stifel

QSII was upgraded from Hold to Buy, Stifel Nicolaus said. $46 price target. Company offers growth at an attractive price.

-----

Rite Aid upgraded at Credit Suisse

RAD was upgraded from Neutral to Outperform, Credit Suisse said. $1.50 price target. Company has multiple potential near-term catalysts.

-----

Rockwell Automation estimates, target increased at UBS

Shares of ROK now seen reaching $79, according to UBS.  Estimates also increased on solid 2012 outlook despite uncertain macro.  Neutral rating.

-----

Rosetta Resources estimates, target increased at BMO

Shares of ROSE now seen reaching $60, according to BMO Capital Markets.  Estimates also raised on lower operating expenses.  Outperform rating.

-----

Rovi downgraded at Brean Murray

ROVI was downgraded from Buy to Hold, Brean Murray said. Company lacks visibility and there is a vacuum of power at the top.

-----

Rovi downgraded at Collins Stewart

ROVI was downgraded from Buy to Neutral, Collins Stewart said. $40 price target. Company slashed its guidance.

-----

Salix Pharmaceuticals estimates increased at UBS
SLXP estimates raised through 2012, UBS said.  Modest accretion from Oceana.  Maintain $32 price target and Neutral rating.

-----

Scotts Miracle-Gro estimates cut at Oppenheimer

SMG estimates were reduced through 2012, Oppenheimer said. Weaker sales are cutting into margins. Perform rating.

-----

Solarwinds estimates, target increased at Morgan Stanley

SWI estimates were raised through 2013, Morgan Stanley said. New products should help drive growth. Underweight rating and new $22 price target.

-----

Solarwinds upgraded at Needham

SWI was upgraded from Hold to Buy, Needham said. $36 price target. Company had an upbeat analyst meeting and can continue to grow.

-----

Sunstone Hotel Investors estimates, target raised at Jefferies

Shares of SHO now seen reaching $8, according to Jefferies. Estimates also raised as management continues to demonstrate solid execution. Hold rating.

-----

Toll Brothers numbers upped at Guggenheim

Shares of TOL now seen reaching $24, according to Guggenheim. Estimates also boosted, as the company is seeing higher orders across the board. Buy rating.

-----

URS Corporation numbers raised at UBS

Shares of URS now seen reaching $38, according to UBS.  Estimates also increased as private sector is expected to lead to 2012 growth.  Neutral rating.

-----

Vertex downgraded at Baird

VRTX was downgraded to Neutral, Robert Baird said. $33 price target. HCV business remains uncertain.

-----

Viacom estimates, target reduced at Wedbush

Shares of VIA.B now seen reaching $55, according to Wedbush Securities. Estimates also cut, given slower expected macro growth. Outperform rating.

-----

Walgreen downgraded at Credit Suisse

WAG was downgraded from Outperform to Neutral, Credit Suisse said. $31 price target. ESRX deal will likely be pushed out until next year.

Columnist Conversations

I have been monitoring the price action of Amazon (AMZN) within the symmetrical triangle formation on its week...
Added to Manpower (MAN)& Kelly Services (KELYA) today. Bought starter positions in Mack-Cali Realty (CLI) ...
What is fascinating about today is that adjusted for the move in the SPX the VIX is actually down on the day. ...
The financial measure visualizations in this post are provided by Capital Market Laboratories (free trial) TK...

BEST IDEAS

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.